Skip to content

130 catalog cards · reviewed 2026-10-09

Know what you’re looking at.

Read the evidence, check the exact identity, and see what remains unknown. Every entry shares its sources and separates research from merchant listings.

130 entries

GLP-1 and incretin · compound

Semaglutide

GLP-1 receptor agonist.

Read evidence and sources
GLP-1 and incretin · compound

Tirzepatide

GIP and GLP-1 receptor agonist.

Read evidence and sources
GH secretagogue · compound

Tesamorelin

Growth-hormone-releasing-hormone analogue.

Read evidence and sources
Healing · compound

Oxytocin

Peptide hormone acting on oxytocin receptors, including uterine muscle.

Read evidence and sources
Melanocortin · compound

PT-141

Bremelanotide is a melanocortin receptor agonist.

Read evidence and sources
Longevity · compound

SS-31

Elamipretide acts on mitochondrial cardiolipin; product-specific evidence matters.

Read evidence and sources
GLP-1 and incretin · compound

Retatrutide

Investigational agonist of GLP-1, GIP and glucagon receptors.

Read evidence and sources
GLP-1 and incretin · compound

Cagrilintide

Investigational long-acting amylin analogue.

Read evidence and sources
GH secretagogue · compound

Sermorelin

Growth-hormone-releasing-hormone analogue.

Read evidence and sources
Healing · compound

BPC-157

Laboratory studies explore tissue repair, growth-factor and nitric-oxide pathways. These mechanisms remain incompletely resolved in humans.

Read evidence and sources
Healing · compound

TB-500

The research name can refer to a thymosin-beta-4 fragment; it is not interchangeable with full-length thymosin beta-4.

Read evidence and sources
GH secretagogue · compound

CJC-1295 (With DAC)

Growth-hormone-releasing-hormone analogue; DAC and non-DAC naming must not be treated as interchangeable.

Read evidence and sources
GH secretagogue · compound

Ipamorelin

Growth-hormone secretagogue acting through the ghrelin receptor.

Read evidence and sources
Healing · compound

GHK-Cu

Copper-binding tripeptide; findings for one formulation cannot establish benefit or safety for another.

Read evidence and sources
Metabolic · compound

MOTS-C

Mitochondrial-derived peptide studied in metabolic signaling.

Read evidence and sources
Melanocortin · compound

Melanotan II

Research melanocortin receptor agonist.

Read evidence and sources
Research compound · compound

Thymosin Alpha-1

Peptide studied for immune modulation.

Read evidence and sources
Metabolic · compound

AOD-9604

Growth-hormone fragment studied in metabolic research.

Read evidence and sources
Healing · compound

KPV

Alpha-MSH-derived tripeptide studied in inflammatory signaling in cells and animal models.

Read evidence and sources
Healing · compound

LL-37

Human cathelicidin peptide involved in innate immune signaling.

Read evidence and sources
Cognitive · compound

Semax

A human therapeutic mechanism is not established in this catalog; laboratory hypotheses do not establish clinical benefit.

Read evidence and sources
Cognitive · compound

Selank

Tuftsin-derived research peptide studied in GABA-related gene expression.

Read evidence and sources
Research compound · compound

DSIP

A human therapeutic mechanism is not established in this catalog; laboratory hypotheses do not establish clinical benefit.

Read evidence and sources
Longevity · compound

Epithalon

A human therapeutic mechanism is not established in this catalog; laboratory hypotheses do not establish clinical benefit.

Read evidence and sources
Cognitive · compound

Dihexa

A human therapeutic mechanism is not established in this catalog; laboratory hypotheses do not establish clinical benefit.

Read evidence and sources
GH secretagogue · compound

MK-677

Ibutamoren is a nonpeptide growth-hormone secretagogue.

Read evidence and sources
Research compound · compound

Kisspeptin

Peptide signaling through the reproductive hormone axis.

Read evidence and sources
Longevity · compound

NAD+

A nonpeptide coenzyme involved in cellular redox reactions.

Read evidence and sources
Metabolic · compound

5-Amino-1MQ

Experimental nonpeptide NNMT inhibitor studied in animal metabolic research.

Read evidence and sources
Metabolic · compound

SLU-PP-332

Experimental nonpeptide estrogen-related-receptor agonist studied in mice.

Read evidence and sources
Longevity · compound

FOXO4-DRI

Experimental peptide studied for disruption of FOXO4-p53 interactions in senescent cells.

Read evidence and sources
GH secretagogue · compound

GHRP-2

Growth-hormone-releasing peptide.

Read evidence and sources
GH secretagogue · compound

GHRP-6

Growth-hormone-releasing peptide.

Read evidence and sources
GH secretagogue · compound

Hexarelin

Growth-hormone-releasing peptide studied for pituitary hormone effects.

Read evidence and sources
Research compound · compound

PEG-MGF

Pegylated growth-factor-related research peptide; product identity and human action are not established here.

Read evidence and sources
Healing · compound

ARA-290 (Cibinetide)

Erythropoietin-derived peptide engineered to target the innate repair receptor without ordinary erythropoietic activity.

Read evidence and sources
Research compound · compound

VIP (Vasoactive Intestinal Peptide)

Endogenous signaling peptide; aviptadil is a synthetic VIP studied in respiratory failure.

Read evidence and sources
Research compound · compound

hCG (Human Chorionic Gonadotropin)

Gonadotropin with LH-like activity affecting gonadal hormone production.

Read evidence and sources
Melanocortin · compound

Melanotan I / Afamelanotide

Alpha-melanocyte-stimulating-hormone analogue; afamelanotide targets melanocortin-1 receptors.

Read evidence and sources
Research compound · compound

Pinealon

Glu-Asp-Arg tripeptide examined in cellular oxidative-stress models.

Read evidence and sources
GH secretagogue · identity guide

CJC-1295 No DAC (Modified GRF 1-29)

Market name for a short-acting modified GHRH analogue without the drug-affinity-complex modification.

Read evidence and sources
Research compound · compound

9-Me-BC (9-Methyl-beta-carboline)

Beta-carboline investigated for dopaminergic neuronal effects in laboratory models.

Read evidence and sources
Research compound · compound

Humanin

Small peptide investigated as a protective signal in neuronal models.

Read evidence and sources
Research compound · compound

Glutathione (GSH)

Endogenous tripeptide involved in cellular redox chemistry.

Read evidence and sources
Research compound · compound

MIF-1

Pro-Leu-Gly-amide neuropeptide examined in neuropsychiatric research.

Read evidence and sources
Research compound · compound

NMN (Nicotinamide Mononucleotide)

Nucleotide intermediate in NAD biosynthesis; NMN and NAD+ are distinct molecules.

Read evidence and sources
Cognitive · compound

Noopept (Omberacetam)

Synthetic dipeptide-derived research nootropic; it is not Semax or Selank.

Read evidence and sources
Research compound · compound

Orexin A (Hypocretin-1)

Hypothalamic neuropeptide involved in sleep and wake signaling.

Read evidence and sources
Research compound · identity guide

P21 / Peptide 021 (Supplier identity)

Research-market P21 is associated by vendors with a CNTF-derived neurotrophic peptide; exact identity requires verification.

Read evidence and sources
Research compound · compound

PE-22-28

Short spadin-derived peptide examined as a TREK-1 channel inhibitor.

Read evidence and sources
Research compound · compound

PNC-27

p53-derived membrane-active peptide examined for binding to membrane-associated HDM-2.

Read evidence and sources
Research compound · identity guide

PNC-28

Distinct shortened p53-derived research peptide related to PNC-27.

Read evidence and sources
Research compound · compound

Salidroside

Rhodiola-associated glycoside; purified salidroside differs from a whole Rhodiola extract.

Read evidence and sources
Research compound · compound

Spermidine

Polyamine investigated in cellular maintenance and aging research.

Read evidence and sources
Research compound · compound

Tesofensine

Investigational monoamine reuptake inhibitor affecting noradrenaline, dopamine and serotonin signaling.

Read evidence and sources
Melanocortin · compound

Setmelanotide

Melanocortin-4 receptor agonist used in an indication-specific prescription product.

Read evidence and sources
Research compound · compound

Thymulin

Thymic peptide studied with zinc-dependent activity and measured in human blood.

Read evidence and sources
Research compound · identity guide

Actogenix

Vendor-branded preparation whose exact active composition requires lot-specific verification.

Read evidence and sources
Research compound · identity guide

CerebroNeurogen

Vendor-branded preparation; a name suggesting Cerebrolysin does not establish chemical or clinical equivalence.

Read evidence and sources
Research compound · identity guide

Cortexin

Named peptide-extract preparation; a heterogeneous extract is not a single defined peptide.

Read evidence and sources
Research compound · identity guide

Adalank

Vendor-named modified Selank-family preparation; modification and sequence are not independently confirmed here.

Read evidence and sources
Research compound · identity guide

Adamax

Vendor-named Semax-family analogue; parent Semax evidence does not validate this modification.

Read evidence and sources
Healing · identity guide

GHK (Copper-free)

Gly-His-Lys peptide sold without copper complexation; it is chemically distinct from GHK-Cu.

Read evidence and sources
Research compound · identity guide

MK-777 (Acetamoren)

Vendor name for a purported GH secretagogue. It is not an established synonym for MK-677 (ibutamoren).

Read evidence and sources
Research compound · identity guide

N-Acetyl Larazotide

Acetylated larazotide-labelled preparation; modification can change identity and pharmacology.

Read evidence and sources
Research compound · identity guide

N-Acetyl Selank

N-terminally modified Selank-labelled preparation.

Read evidence and sources
Research compound · identity guide

N-Acetyl Selank Amidate

Distinct acetylated and amidated Selank-labelled preparation.

Read evidence and sources
Research compound · identity guide

N-Acetyl Semax

N-terminally modified Semax-labelled preparation.

Read evidence and sources
Research compound · identity guide

N-Acetyl Semax Amidate

Distinct acetylated and amidated Semax-labelled preparation.

Read evidence and sources
Research compound · identity guide

Thymosin Beta-4 Fragment 1-4

A short fragment-labelled product, not full-length thymosin beta-4 or the 17-23 fragment.

Read evidence and sources
Research compound · identity guide

Thymosin Beta-4 Fragment 17-23

A fragment-labelled product, distinct from the 1-4 fragment and full-length thymosin beta-4.

Read evidence and sources
Research compound · identity guide

Thymosin Alpha-1 RGDR

Modified TA1-labelled preparation; sequence extension requires separate evidence.

Read evidence and sources
Research compound · identity guide

Bronchogen

Short-peptide or bioregulator product name. The exact sequence and preparation must be established from the current label.

Read evidence and sources
Research compound · identity guide

CardioCytogen

Short-peptide or bioregulator product name. The exact sequence and preparation must be established from the current label.

Read evidence and sources
Research compound · identity guide

Livagen

Short-peptide or bioregulator product name. The exact sequence and preparation must be established from the current label.

Read evidence and sources
Research compound · identity guide

Pancragen

Short-peptide or bioregulator product name. The exact sequence and preparation must be established from the current label.

Read evidence and sources
Research compound · identity guide

Prostamax

Short-peptide or bioregulator product name. The exact sequence and preparation must be established from the current label.

Read evidence and sources
Research compound · identity guide

Testagen

Short-peptide or bioregulator product name. The exact sequence and preparation must be established from the current label.

Read evidence and sources
Research compound · compound

Larazotide (AT-1001)

Tight-junction-regulator peptide examined in celiac disease.

Read evidence and sources
Research compound · supplement

PEA (Palmitoylethanolamide)

Endogenous fatty-acid amide investigated for pain-related signaling.

Read evidence and sources
Research compound · supplement

TUDCA (Tauroursodeoxycholic Acid)

Taurine-conjugated bile acid investigated in disease-specific settings.

Read evidence and sources
Research compound · supplement

Dihydromyricetin (DHM)

Botanical flavonoid examined for effects related to alcohol signaling in experimental models.

Read evidence and sources
Research compound · supplement

Lactoferrin

Iron-binding milk-associated protein; commercial bovine formulations and human lactoferrin differ.

Read evidence and sources
Research compound · supplement

Tongkat Ali (Eurycoma longifolia)

Botanical extract studied in selected endocrine and sexual-function settings.

Read evidence and sources
Research compound · supplement

Cistanche tubulosa

Botanical stem extract; standardization and species matter.

Read evidence and sources
Research compound · supplement

Shilajit

Complex mineral-organic preparation. Purification and contaminant testing matter to identity.

Read evidence and sources
Research compound · supplement

Turkesterone

Ecdysteroid-associated supplement ingredient; it is distinct from ecdysterone.

Read evidence and sources
Research compound · formulation

777 (LVLUP formula)

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Botanabolic

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Complete Liver Complex

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Crevolution

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Hista-Resist

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Hormone Harmony

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Longevity (LVLUP formula)

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Mag Max

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Mito Blue

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Neuro Regenerate

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

NootroPept

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

PQQ + Ubiquinol

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Re-Generate

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

TB4 Frags (LVLUP formula)

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Total Recomp

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

TUDCA + Ox Bile

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Ultimate GI Repair

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

VO2-MAX

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Wolverine (LVLUP oral formula)

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

Zinc Carnosine +

Branded multi-ingredient formulation; its individual ingredients can have different evidence and pharmacology.

Read evidence and sources
Research compound · formulation

FIT (Ascension blend)

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · formulation

Wolverine (Ascension blend)

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · formulation

GLOW (Ascension blend)

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · formulation

KLOW (Ascension blend)

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · formulation

CJC-1295 No DAC + Ipamorelin (Limitless blend)

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · formulation

MOTS-C + Humanin (Limitless blend)

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · formulation

Adamax + Adalank (Limitless combo)

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · formulation

N-Acetyl Semax Amidate + N-Acetyl Selank Amidate (Limitless blend)

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · formulation

Gastro Inflammation Research Formula

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · formulation

Healing and Repair Research Blend

Distinct multi-ingredient research formulation. A blend name does not define a universal composition.

Read evidence and sources
Research compound · identity guide

Age Defying Wrinkle Reduction Cream

Topical cosmetic product; complete INCI ingredient list requires a verified current label.

Read evidence and sources
Research compound · supply

Acetic Acid Reconstitution Solution

Labelled dilute acidic laboratory solution. A chemical identity does not establish sterility or suitability for human administration.

Read evidence and sources
Research compound · supply

Reconstitution Solution

Diluent-labelled product. Exact composition, preservative status and intended use require the current label.

Read evidence and sources
Research compound · supply

Sprayer with Sterile Water

Container and water-labelled supply. Route, microbiological status and preservative content cannot be inferred from a product title.

Read evidence and sources
Research compound · supply

Empty / Sterile Vial

Container supply. Supplier sterility claims and intended use require lot-specific documentation.

Read evidence and sources
Research compound · supply

Milligram Scale

Measuring equipment. Display resolution is not measurement accuracy; calibration and uncertainty matter.

Read evidence and sources
Research compound · supply

Shaker Bottle

Reusable drinking container. Color variants share a supply guide, not a therapeutic profile.

Read evidence and sources
Research compound · supply

Daily Organizer

Storage/organization accessory. Compartments do not establish product stability, contamination control or a treatment schedule.

Read evidence and sources
Research compound · formulation

Larazotide (LVLUP formula)

Branded larazotide-labelled mixture; marketed modified forms differ from trial larazotide acetate.

Read evidence and sources
Research compound · formulation

BPC-157 Double Strength (LVLUP oral formula)

Multi-ingredient oral formula containing Hyaluronic acid, PEA, BPC-157, Sodium bicarbonate. These are listed identities, not claims of verified clinical benefit.

Read evidence and sources
Research compound · formulation

KPV (LVLUP oral formula)

Multi-ingredient oral formula containing Hyaluronic acid, KPV, PEA, Sodium bicarbonate. These are listed identities, not claims of verified clinical benefit.

Read evidence and sources
Research compound · formulation

GHK-Cu (LVLUP oral formula)

Multi-ingredient oral formula containing Hyaluronic acid, Liposomal GHK-Cu, PEA, Sodium bicarbonate. These are listed identities, not claims of verified clinical benefit.

Read evidence and sources
Research compound · compound

P021 (Experimental peptide)

Research-market P21 is associated by vendors with a CNTF-derived neurotrophic peptide; exact identity requires verification.

Read evidence and sources